The RFS of PR-positive patients also had a longer RFS as ZG16B expressed higher (HR = 0.62, p = 0.014) (Figure 7d), but there is no significance in other types of breast cancer (Figure 7b, c and e–k). This evidence concerns the gene PGR and breast cancer.